Cases with Castle: A case study webinar on ambiguous melanocytic lesions - Dr. Alexander Witkowski

When to Use MyPath Melanoma: Dr. Neil Fernandes on Managing Ambiguous Skin LesionsПодробнее

Cases with Castle Biosciences - Drazen Jukic, M.D., Ph.D.Подробнее

Cases with Castle: A melanoma case study series presented by Dr. Angela WingfieldПодробнее

How MyPath Melanoma Test Aids in Diagnosing Challenging Skin Lesions: Dr. Abel Jarrell ExplainsПодробнее

When to Use MyPath Melanoma: Dr. Shannon Trotter on Diagnosing Ambiguous Skin LesionsПодробнее

Confirming Difficult Diagnoses in Melanocytic Lesions with MyPath MelanomaПодробнее

Cases with Castle Biosciences - Barry White, M.D.Подробнее

Cases with Castle: Resolving diagnostic ambiguity using GEP testing - Dr. Clay CockerellПодробнее

How MyPath Melanoma Helps Diagnose Challenging Melanocytic LesionsПодробнее

Cases with Castle: Learn how MyPath Melanoma can help differentiate between different diagnosesПодробнее

Advice for Anyone Facing Melanoma or Skin Cancer: Advocate for Yourself and Stay InformedПодробнее

Cases with Castle Biosciences - Etan Marks, DOПодробнее

How DecisionDx-Melanoma works and data supporting itПодробнее

Dr. Dmitriy Timerman on Diagnosing Atypical Skin Lesions & Surgical Precision with MyPath MelanomaПодробнее

How DecisionDx-Melanoma Guides Pre- and Post-Operative Care: Insights from Surgical OncologistПодробнее

When to Use MyPath Melanoma: Solving Ambiguity in Diagnosing Pigmented LesionsПодробнее

How MyPath Melanoma Resolves Uncertainty in Diagnosing Skin LesionsПодробнее

CDO - Highly accurate & objective tests for melanocytic lesions of uncertain malignant potentialПодробнее

How MyPath Melanoma Test Helps Avoid Large Surgeries:Подробнее